Screener
Crinetics Pharmaceuticals CRNX Business Segments — Expenses Related To Atumelnant
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept crnx:ExpensesRelatedToAtumelnant.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Cost of product revenue | (200) | — |
| Research and development | ||
| Paltusotine | (11,869) | (17,251) |
| Atumelnant | (20,267) | (7,749) |
| Other research and development programs | (9,667) | (7,058) |
| Research and development personnel expenses | (30,649) | (25,627) |
| Research and development stock-based compensation | (19,328) | (11,819) |
| Other research and development (1) | (8,301) | (6,736) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's business segments — expenses related to atumelnant?
- Crinetics Pharmaceuticals (CRNX) reported business segments — expenses related to atumelnant of $20.27M in Q1 2026.
- How has Crinetics Pharmaceuticals's business segments — expenses related to atumelnant changed year-over-year?
- Crinetics Pharmaceuticals's business segments — expenses related to atumelnant increased by 161.5% year-over-year, from $7.75M to $20.27M.
- What does business segments — expenses related to atumelnant mean?
- This metric measures the total investment directed toward the research and development of the Atumelnant program. It reflects the financial resources dedicated to advancing this specific candidate through the clinical pipeline. High or increasing levels indicate active development efforts and the prioritization of this asset within the company's R&D strategy.
Ask your AI about Crinetics Pharmaceuticals's business segments — expenses related to atumelnant.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude